All Stories

  1. Direct cost analysis of diagnostic pathways for acute vulvovaginal candidiasis in Uganda: a modelling study

    Article • Open Forum Infectious Diseases, October 2026, Oxford University Press (OUP)

    Dr Gerald Mboowa

  2. Uganda’s Mandatory Newborn Sickle Cell Disease Screening Programme: Translating a Decade of Evidence into Differentiated Implementation

    Article • Pediatric Health Medicine and Therapeutics, September 2026, Taylor & Francis

    Dr Gerald Mboowa

  3. Genomic characterization of two Staphylococcus aureus isolates from a Tanzanian orthopaedics ward: a fomite-associated ST152 MSSA isolate and a rectal-swab ST8 mecA-positive isolate

    Article • BMC Genomic Data, August 2026, Springer Science + Business Media

    Dr Gerald Mboowa

  4. Genomic characterization of ESBL-producing Escherichia coli isolates from patients in an orthopaedic ward in Mwanza, Tanzania

    Article • F1000Research, June 2026, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  5. Genomic characterization of ESBL-producing Escherichia coli isolates from patients in an orthopaedic ward in Mwanza, Tanzania

    Article • F1000Research, May 2026, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  6. Conserved neutrophil degranulation transcripts in HIV-TB coinfected children across East and Southern Africa

    Article • Communications Medicine, March 2026, Springer Science + Business Media

    Dr Gerald Mboowa

  7. Decade-long antiretroviral therapy in Uganda: Population-health outcomes from a national HIV treatment cohort, 2014–2024

    Article • PLOS Global Public Health, March 2026, PLOS

    Dr Gerald Mboowa

  8. rMAP 2.0: A modular, reproducible and scalable WDL-Cromwell-Docker workflow for genomic analysis of ESKAPEE pathogens

    Article • Bioinformatics Advances, February 2026, Oxford University Press (OUP)

    Dr Gerald Mboowa

  9. Multicountry genomic analysis underscores regional cholera spread in Africa

    Article • Nature Communications, February 2026, Springer Science + Business Media

    Dr Gerald Mboowa

  10. Pathways, outputs and impact of NIH-supported bioinformatics and genomics graduate trainees in Africa

    Article • Briefings in Bioinformatics, January 2026, Oxford University Press (OUP)

    Dr Gerald Mboowa

  11. Harnessing Genomics for Public Health: Use-Case Insights from Uganda

    Article • December 2025, MDPI AG

    Dr Gerald Mboowa

  12. Burden of sickle cell anemia in Africa: A systematic review and meta-analysis

    Article • PLOS One, November 2025, PLOS

    Dr Gerald Mboowa, Dr. Richard Kwizera

  13. A clinical milestone for CRISPR in sickle-cell disease

    Article • Nature Reviews Genetics, September 2025, Springer Science + Business Media

    Dr Gerald Mboowa

  14. Reimagining Tuberculosis Control in the Era of Genomics: The Case for Global Investment in Mycobacterium tuberculosis Genomic Surveillance

    Article • Pathogens, September 2025, MDPI AG

    Dr Gerald Mboowa

  15. Genomic characterization of Citrobacter freundii clinical isolates from Tanzania

    Article • Microbiology Resource Announcements, July 2025, ASM Journals

    Dr Gerald Mboowa

  16. Extracellular hydrolytic enzyme activities and biofilm formation in Candida species isolated from people living with human immunodeficiency virus with oropharyngeal candidiasis at HIV/AIDS clinics in Uganda

    Article • Microbial Pathogenesis, February 2025, Elsevier

    Dr Gerald Mboowa

  17. Unlocking the future of complex human diseases prediction: multi-omics risk score breakthrough

    Article • Frontiers in Bioinformatics, December 2024, Frontiers

    Dr Gerald Mboowa

  18. High KIR diversity in Uganda and Botswana children living with HIV

    Article • December 2024, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa

  19. Machine learning-based prediction of antibiotic resistance in Mycobacterium tuberculosis clinical isolates from Uganda

    Article • BMC Infectious Diseases, December 2024, Springer Science + Business Media

    Dr Gerald Mboowa

  20. Reported prevalence and comparison of diagnostic approaches for Candida africana: a systematic review with meta-analysis

    Article • Diagnostic and Prognostic Research, December 2024, Springer Science + Business Media

    Dr Gerald Mboowa

  21. Whole genome-based characterization of extended-spectrum β-lactamase-producing Enterobacter cloacae from orthopedic patients and environment of a tertiary referral hospital in Tanzania

    Article • New Microbes and New Infections, December 2024, Elsevier

    Dr Gerald Mboowa

  22. Multicountry genomic analysis underscores regional cholera spread in Africa

    Article • November 2024, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa

  23. Inclusiveness of the All of Us Research Program improves polygenic risk scores and fosters genomic medicine for all

    Article • Communications Medicine, November 2024, Springer Science + Business Media

    Dr Gerald Mboowa

  24. Serological Status of Vaccine and Hepatitis B Virus Exposure Among Children Under 5 and Aged 15–17 Years in Kampala, Uganda

    Article • Livers, October 2024, MDPI AG

    Dr Gerald Mboowa

  25. Lack of Candida africana in Ugandan pregnant women: results from a pilot study using MALDI-ToF

    Article • BMC Research Notes, October 2024, Springer Science + Business Media

    Dr Gerald Mboowa

  26. The rise of pathogen genomics in Africa

    Article • F1000Research, September 2024, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  27. Africa in the era of pathogen genomics: Unlocking data barriers

    Article • Cell, September 2024, Elsevier

    Dr Gerald Mboowa

  28. Metagenomics insights into the microbial resistome and virulome composition of Kampala’s wastewater

    Article • Open Research Africa, July 2024, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  29. CDC Trioplex diagnostic assay underperforms in detection of circulating Chikungunya West African genotype

    Article • Journal of Clinical Microbiology, July 2024, ASM Journals

    Dr Gerald Mboowa

  30. The pandemic agreement: an African perspective

    Article • Nature, July 2024, Springer Science + Business Media

    Dr Gerald Mboowa

  31. HIV-DRIVES: HIV drug resistance identification, variant evaluation, and surveillance pipeline

    Article • Access Microbiology, July 2024, Society for General Microbiology

    Dr Gerald Mboowa

  32. HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance Pipeline

    Article • June 2024, Society for General Microbiology

    Dr Gerald Mboowa

  33. Genomic epidemiology uncovers the timing and origin of the emergence of mpox in humans

    Article • June 2024, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa

  34. Molecular epidemiology of recurrent zoonotic transmission of mpox virus in West Africa

    Article • June 2024, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa

  35. Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda

    Article • The Journal of Infectious Diseases, June 2024, Oxford University Press (OUP)

    Dr Gerald Mboowa

  36. Prevalence of Oropharyngeal Candidiasis and distribution of Candida species among People Living with Human Immunodeficiency Virus in Africa: a systematic review and meta-analysis

    Article • June 2024, Research Square

    Dr Gerald Mboowa

  37. The rise of pathogen genomics in Africa

    Article • F1000Research, May 2024, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  38. Peer Review of “Establishing Antimicrobial Resistance Surveillance in the Water and Environment Sector in a Resource-Limited Setting: Methodical Qualitative and Quantitative Description of Uganda’s Experience From 2021 to 2023”

    Article • JMIRx Bio, May 2024, JMIR Publications Inc.

    Dr Gerald Mboowa

  39. In Vitro Evaluation of the Virulence Attributes of Oropharyngeal Candida Species Isolated from People Living with Human Immunodeficiency Virus with Oropharyngeal Candidiasis on Antiretroviral Therapy

    Article • May 2024, Springer Science + Business Media

    Dr Gerald Mboowa

  40. HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance Pipeline

    Article • March 2024, Society for General Microbiology

    Dr Gerald Mboowa

  41. The dawn of a cure for sickle cell disease through CRISPR‐based treatment: A critical test of equity in public health genomics

    Article • Annals of Human Genetics, March 2024, Wiley

    Dr Gerald Mboowa

  42. Generalizability of machine learning in predicting antimicrobial resistance in E. coli: a multi-country case study in Africa

    Article • BMC Genomics, March 2024, Springer Science + Business Media

    Dr Gerald Mboowa

  43. Climate-influenced vector-borne diseases in Africa: a call to empower the next generation of African researchers for sustainable solutions

    Article • Infectious Diseases of Poverty, March 2024, Springer Science + Business Media

    Dr Gerald Mboowa

  44. Distribution and antifungal susceptibility profile of oropharyngeal Candida species isolated from people living with HIV in the era of universal test and treat policy in Uganda

    Article • Therapeutic Advances in Infectious Disease, January 2024, SAGE Publications

    Dr Gerald Mboowa

  45. A systematic review reveals that African children of 15–17 years demonstrate low hepatitis B vaccine seroprotection rates

    Article • Scientific Reports, December 2023, Springer Science + Business Media

    Dr Gerald Mboowa

  46. A Digital One Health framework to integrate data for public health decision-making

    Article • IJID One Health, December 2023, Elsevier

    Dr Gerald Mboowa

  47. Virulence genes and plasmid replicon profiles of selected β-lactamase-producing Acinetobacter baumannii from orthopaedic patients and the environment in a tertiary referral hospital in Tanzania, East Africa

    Article • Journal of Hospital Infection, November 2023, Elsevier

    Dr Gerald Mboowa

  48. Reviewing the journey to the clinical application of bacteriophages to treat multi-drug-resistant bacteria

    Article • BMC Infectious Diseases, October 2023, Springer Science + Business Media

    Dr Gerald Mboowa

  49. HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance Pipeline

    Article • October 2023, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa

  50. Unraveling virulence determinants in extended-spectrum beta-lactamase-producing Escherichia coli from East Africa using whole-genome sequencing

    Article • BMC Infectious Diseases, September 2023, Springer Science + Business Media

    Dr Gerald Mboowa

  51. Reduced CCR5 expression among Uganda HIV controllers

    Article • Retrovirology, May 2023, Springer Science + Business Media

    Dr Gerald Mboowa

  52. Unlocking the Potential of Genomic Data to Inform Typhoid Fever Control Policy: Supportive Resources for Genomic Data Generation, Analysis, and Visualization

    Article • Open Forum Infectious Diseases, May 2023, Oxford University Press (OUP)

    Dr Gerald Mboowa

  53. A pan-African pathogen genomics data sharing platform to support disease outbreaks

    Article • Nature Medicine, May 2023, Springer Science + Business Media

    Dr Gerald Mboowa

  54. Metatranscriptomic analysis of the gut microbiome of black soldier fly larvae reared on lignocellulose-rich fiber diets unveils key lignocellulolytic enzymes

    Article • Frontiers in Microbiology, April 2023, Frontiers

    Dr Gerald Mboowa

  55. Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS,S/AS01 vaccine

    Article • Immunogenetics, April 2023, Springer Science + Business Media

    Dr Gerald Mboowa

  56. Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review

    Article • Frontiers in Microbiology, April 2023, Frontiers

    Dr Gerald Mboowa

  57. No association of a Vascular endothelial growth factor A (VEGFA) gene polymorphism with pre-eclampsia among pregnant women in Uganda

    Article • BMC Genomics, March 2023, Springer Science + Business Media

    Dr Gerald Mboowa

  58. Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020–2022

    Article • Genes, March 2023, MDPI AG

    Dr Gerald Mboowa

  59. Prevalence and antimicrobial resistance profiles of Neisseria gonorrhea and Chlamydia trachomatis isolated from individuals attending STD clinics in Kampala, Uganda

    Article • African Health Sciences, October 2022, African Journals Online (AJOL)

    Dr Gerald Mboowa, Willy SSENGOOBA

  60. The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

    Article • Science, October 2022, American Association for the Advancement of Science

    Dr Gerald Mboowa, Prof. Kwabena Obeng Duedu, Dr Oluwapelumi Adeyemi O Adeyemi, Dr Olubusuyi Moses Adewumi

  61. Microbial characteristics of dental caries in HIV positive individuals

    Article • Frontiers in Oral Health, September 2022, Frontiers

    Dr Gerald Mboowa

  62. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus

    Article • PLoS Biology, August 2022, PLOS

    Christian Happi, Dr Gerald Mboowa

  63. Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania

    Article • BMC Genomics, August 2022, Springer Science + Business Media

    Dr Gerald Mboowa

  64. Next-generation sequencing (NGS) reveals low-abundance HIV-1 drug resistance mutations among patients experiencing virological failure at the time of therapy switching in Uganda

    Article • F1000Research, August 2022, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  65. Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries

    Article • Global Health Action, June 2022, Taylor & Francis

    Dr Gerald Mboowa

  66. Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda

    Article • IJID Regions, June 2022, Elsevier

    Dr Gerald Mboowa, Dr. Richard Kwizera

  67. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda

    Article • Antimicrobial Resistance and Infection Control, May 2022, Springer Science + Business Media

    Dr Gerald Mboowa

  68. The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

    Article • April 2022, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa, Prof. Kwabena Obeng Duedu

  69. Genetic Diversity, Distribution, and Genomic Characterization of Antibiotic Resistance and Virulence of Clinical Pseudomonas aeruginosa Strains in Kenya

    Article • Frontiers in Microbiology, March 2022, Frontiers

    Dr Gerald Mboowa

  70. Genetic Diversity of Bundibugyo Ebolavirus from Uganda and the Democratic Republic of Congo

    Article • October 2021, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa

  71. Bioinformatics mentorship in a resource limited setting

    Article • Briefings in Bioinformatics, September 2021, Oxford University Press (OUP)

    Dr Gerald Mboowa

  72. Transmission Dynamics of Antimicrobial Resistance at a National Referral Hospital in Uganda

    Article • American Journal of Tropical Medicine and Hygiene, August 2021, American Society of Tropical Medicine and Hygiene

    Dr Gerald Mboowa

  73. Whole-genome sequencing of SARS-CoV-2 in Uganda: implementation of the low-cost ARTIC protocol in resource-limited settings

    Article • F1000Research, July 2021, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  74. Knowledge and attitude of secondary school students in Nakaseke, Uganda towards HIV transmission and treatment

    Article • AAS Open Research, July 2021, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  75. rMAP: the Rapid Microbial Analysis Pipeline for ESKAPE bacterial group whole-genome sequence data

    Article • Microbial Genomics, June 2021, Society for General Microbiology

    Dr Gerald Mboowa

  76. Increasing Antimicrobial Resistance in Surgical Wards at Mulago National Referral Hospital, Uganda, from 2014 to 2018—Cause for Concern?

    Article • Tropical Medicine and Infectious Disease, May 2021, MDPI AG

    Dr Gerald Mboowa

  77. Knowledge and attitude of secondary school students in Nakaseke, Uganda towards HIV transmission and treatment

    Article • AAS Open Research, May 2021, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  78. Efficacy of Face Masks Used in Uganda: A Laboratory-Based Inquiry during the COVID-19 Pandemic

    Article • American Journal of Tropical Medicine and Hygiene, May 2021, American Society of Tropical Medicine and Hygiene

    Dr Gerald Mboowa

  79. Gastrointestinal Tract Colonization Rate of Extended-Spectrum Beta-Lactamase-Producing Gram-Negative Bacteria and Associated Factors Among Orthopaedic Patients in a Tertiary Hospital in Tanzania: Implications for Infection Prevention

    Article • Infection and Drug Resistance, May 2021, Taylor & Francis

    Dr Gerald Mboowa

  80. Genomics and bioinformatics capacity in Africa: no continent is left behind

    Article • Genome, May 2021, Canadian Science Publishing

    Dr Gerald Mboowa

  81. Unmapped exome reads implicate a role for Anelloviridae in childhood HIV-1 long-term non-progression

    Article • npj Genomic Medicine, March 2021, Springer Science + Business Media

    Dr Gerald Mboowa

  82. Face-Masking, an Acceptable Protective Measure against COVID-19 in Ugandan High-Risk Groups

    Article • American Journal of Tropical Medicine and Hygiene, December 2020, American Society of Tropical Medicine and Hygiene

    Dr Gerald Mboowa

  83. Efficacy of face-masks used in Uganda: a laboratory-based inquiry during the COVID-19 pandemic

    Article • September 2020, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa

  84. Re-thinking antimicrobial resistance transmission dynamics: a meta-analysis of cross-sectional studies at referral hospitals in Uganda

    Article • F1000Research, August 2020, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  85. Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study

    Article • Retrovirology, July 2020, Springer Science + Business Media

    Dr Gerald Mboowa, Rebecca Nakaziba

  86. Whole-genome sequence analysis reveals evolution of antimicrobial resistance in a Ugandan colistin resistant Acinetobacter baumannii

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Dr Gerald Mboowa

  87. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda

    Article • PLOS One, May 2020, PLOS

    Willy SSENGOOBA, Dr Gerald Mboowa

  88. Current and emerging diagnostic tests available for the novel COVID-19 global pandemic

    Article • AAS Open Research, April 2020, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  89. blaVIM- and blaOXA-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda

    Article • BMC Infectious Diseases, October 2019, Springer Science + Business Media

    Dr Gerald Mboowa

  90. Whole-genome sequence analysis of Vibrio cholerae from three outbreaks in Uganda, 2014 - 2016

    Article • F1000Research, August 2019, Faculty of 1000, Ltd.

    Ivan Sserwadda, Dr Gerald Mboowa, Dickson Aruhomukama

  91. Comprehensive genomic analysis of Vibrio cholerae from three outbreaks in Uganda, 2014 - 2016

    Article • July 2019, Research Square

    Dr Gerald Mboowa

  92. Role of genomics literacy in reducing the burden of common genetic diseases in Africa

    Article • Molecular Genetics & Genomic Medicine, May 2019, Wiley

    Dr Gerald Mboowa

  93. Investigating colistin drug resistance: The role of high-throughput sequencing and bioinformatics

    Article • F1000Research, May 2019, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  94. Investigating colistin drug resistance: The role of high-throughput sequencing and bioinformatics

    Article • F1000Research, February 2019, Faculty of 1000, Ltd.

    Dickson Aruhomukama, Ivan Sserwadda, Dr Gerald Mboowa

  95. The Collaborative African Genomics Network (CAfGEN): Applying Genomic technologies to probe host factors important to the progression of HIV and HIV-tuberculosis infection in sub-Saharan Africa

    Article • AAS Open Research, June 2018, Faculty of 1000, Ltd.

    Dr Gerald Mboowa

  96. Whole-Exome Sequencing Reveals Uncaptured Variation and Distinct Ancestry in the Southern African Population of Botswana

    Article • The American Journal of Human Genetics, May 2018, Elsevier

    Dr Gerald Mboowa

  97. Microbial contaminants isolated from items and work surfaces in the post- operative ward at Kawolo general hospital, Uganda

    Article • BMC Infectious Diseases, February 2018, Springer Science + Business Media

    Ivan Sserwadda, Dr Gerald Mboowa

  98. Human Genomic Loci Important in Common Infectious Diseases: Role of High-Throughput Sequencing and Genome-Wide Association Studies

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2018, Hindawi Publishing Corporation

    Ivan Sserwadda, Dr Gerald Mboowa

  99. The collaborative African genomics network training program: a trainee perspective on training the next generation of African scientists

    Article • Genetics in Medicine, July 2017, Elsevier

    Dr Gerald Mboowa

  100. Serological and molecular investigation for brucellosis in swine in selected districts of Uganda

    Article • Tropical Animal Health and Production, May 2016, Springer Science + Business Media

    Dr Gerald Mboowa

  101. Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics

    Article • PLOS One, September 2015, PLOS

    Dr Gerald Mboowa

  102. High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals

    Article • PLOS One, July 2015, PLOS

    Willy SSENGOOBA, Dr Gerald Mboowa

  103. Improving the Sensitivity of the Xpert MTB/RIF Assay on Sputum Pellets by Decreasing the Amount of Added Sample Reagent: a Laboratory and Clinical Evaluation

    Article • Journal of Clinical Microbiology, February 2015, ASM Journals

    Willy SSENGOOBA, Dr Gerald Mboowa

  104. Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda

    Article • Health Research Policy and Systems, January 2015, Springer Science + Business Media

    Willy SSENGOOBA, Dr Gerald Mboowa

  105. Seroprevalence of Syphilis among Human Immunodeficiency Virus Positive Individuals Attending Immune Suppressed Syndrome Clinic at International Hospital Kampala, Uganda

    Article • International STD Research & Reviews, January 2015, Sciencedomain International

    Dr Gerald Mboowa

  106. Isolation and Molecular Characterization ofBrucellaIsolates in Cattle Milk in Uganda

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Dr Gerald Mboowa

  107. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert®MTB/RIF in Kampala, Uganda: a retrospective study

    Article • BMC Infectious Diseases, September 2014, Springer Science + Business Media

    Willy SSENGOOBA, Dr Gerald Mboowa

  108. Genetics of Sub-Saharan African Human Population: Implications for HIV/AIDS, Tuberculosis, and Malaria

    Article • International Journal of Evolutionary Biology, August 2014, Hindawi Publishing Corporation

    Dr Gerald Mboowa

  109. Clinico-pathological features of tuberculosis due to Mycobacterium tuberculosis Uganda genotype in patients with tuberculous lymphadenitis: a cross sectional study

    Article • BMC Clinical Pathology, April 2014, Springer Science + Business Media

    Dr Gerald Mboowa

  110. Tuberculosis and Genetics of Sub-Saharan Africa Human Population

    Article • Mycobacterial Diseases, January 2014, OMICS Publishing Group

    Dr Gerald Mboowa

  111. Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs

    Article • Antimicrobial Agents and Chemotherapy, October 2013, ASM Journals

    Willy SSENGOOBA, Dr Gerald Mboowa

  112. Cough Aerosols of Mycobacterium tuberculosis Predict New Infection. A Household Contact Study

    Article • American Review of Respiratory Disease, May 2013, American Thoracic Society

    Dr Gerald Mboowa

  113. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda

    Article • BMC Infectious Diseases, February 2013, Springer Science + Business Media

    Willy SSENGOOBA, Dr Gerald Mboowa

  114. An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda

    Article • Tuberculosis Research and Treatment, January 2012, Hindawi Publishing Corporation

    Willy SSENGOOBA, Dr Gerald Mboowa